NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance. Bonnard B, El Moghrabi S, Ueda K, Lattenist L, et al. Hypertension 2023 Jun 28. doi: 10.1161/HYPERTENSIONAHA.123.21156.

Read + Share

Amedeo Smart

Independent Medical Education

Bonnard B, El Moghrabi S, Ueda K, Lattenist L, et al. NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance. Hypertension 2023 Jun 28. doi: 10.1161/HYPERTENSIONAHA.123.21156.
PMID: 37377014